Expression of circulatory dendritic cells and regulatory T-cells in patients with different subsets of coronary artery disease

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 5, 2011, Pages 542-549

  Kofler, Sieglinde ^a   Sisic, Zeljka ^a   Shvets, Nataliya ^a   Lohse, Peter ^a   Weis, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

acute coronary syndrome; atherosclerosis; coronary artery disease; dendritic cells; HSP 60

Indexed keywords

CD123 ANTIGEN; CD86 ANTIGEN; FAS LIGAND; HEAT SHOCK PROTEIN 60; T6 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENDRITIC CELL; DOWN REGULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UPREGULATION;

ADAPTIVE IMMUNITY; AGED; CELL LINE; CORONARY ARTERY DISEASE; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; T-LYMPHOCYTES, REGULATORY;

EID: 79957773179     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182124c53     Document Type: Article

References (32)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695
2. Hansson GK, Libby P. The immune response in atherosclerosis: a doubleedged sword. Nat Rev Immunol. 2006;6:508-519 (Pubitemid 43980523)
3. Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res. 2002;91:281-291 (Pubitemid 34976993)
4. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83:S456-S460
5. Methe H, Weis M. Atherogenesis and inflammation-was Virchow right? Nephrol Dial Transplant. 2007;22:1823-1827
6. Bobryshev YV, Lord RS. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta. Arch Histol Cytol. 1995;58:307-322
7. Millonig G, Niederegger H, RablW, et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol. 2001;21:503-508 (Pubitemid 32323380)
8. Niessner A, Sato K, Chaikof EL, et al. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation. 2006;114:2482-2489 (Pubitemid 44901521)
9. Yilmaz A, Weber J, Cicha I, et al. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J Am Coll Cardiol. 2006;48:70-80 (Pubitemid 43929209)
10. Methe H, Kim JO, Kofler S, et al. Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation. 2005;111:2654-2661 (Pubitemid 40740866)
11. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408 (Pubitemid 34164012)
12. Sansom DM, Manzotti CN, Zheng Y. What's the difference between CD80 and CD86? Trends Immunol. 2003;24:314-319
13. Blum A, Chaperot L, Molens JP, et al. Mechanisms of TRAIL-induced apoptosis in leukemic plasmacytoid dendritic cells. Exp Hematol. 2006; 34:1655-1662 (Pubitemid 44839006)
14. Chaperot L, Blum A, Manches O, et al. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol. 2006;176:248-255 (Pubitemid 43023269)
15. Van Vre EA, Hoymans VY, Bult H, et al. Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. Coron Artery Dis. 2006;17:243-248 (Pubitemid 44324834)
16. Shi H, Ge J, Fang W, et al. Peripheral-blood dendritic cells in men with coronary heart disease. Am J Cardiol. 2007;100:593-597 (Pubitemid 47223132)
17. Erbel C, Sato K, Meyer FB, et al. Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol. 2007;102: 123-132 (Pubitemid 46189953)
18. Llodra J, Angeli V, Liu J, et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A. 2004;101:11779-11784 (Pubitemid 39095371)
19. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol. 2005;5: 617-628 (Pubitemid 41113193)
20. Randolph GJ, Ochando J, Partida-Sanchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol. 2008;26:293-316 (Pubitemid 351600378)
21. Dopheide JF, Sester U, Schlitt A, et al. Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro. Coron Artery Dis. 2007;18:523-531 (Pubitemid 47556383)
22. de Boer OJ, van der Meer JJ, Teeling P, et al. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE. 2007;2:e779
23. Gotsman I, Gupta R, Lichtman AH. The influence of the regulatory T lymphocytes on atherosclerosis. Arterioscler Thromb Vasc Biol. 2007; 27:2493-2495 (Pubitemid 350158897)
24. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 2004;200:277-285 (Pubitemid 39031247)
25. Kukreja A, Cost G, Marker J, et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest. 2002;109:131-140 (Pubitemid 34052549)
26. Mor A, Luboshits G, Planer D, et al. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J. 2006;27:2530-2537 (Pubitemid 44627295)
27. Han SF, Liu P, Zhang W, et al. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol. 2007;124:90-97 (Pubitemid 46936250)
28. Zal B, Kaski JC, Arno G, et al. Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. Circulation. 2004;109:1230-1235 (Pubitemid 38372781)
29. Buckland M, Jago CB, Fazekasova H, et al. Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells. Am J Transplant. 2006;6:2046-2059 (Pubitemid 44199539)
30. Buckland M, Lombardi G. Aspirin and the induction of tolerance by dendritic cells. Handb Exp Pharmacol. 2009;188:197-213
31. Xia CQ, Kao KJ. Heparin induces differentiation of CD1a+ dendritic cells from monocytes: phenotypic and functional characterization. J Immunol. 2002;168:1131-1138
32. Schmidt-Lucke C, Aicher A, Romagnani P, et al. Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients. Am J Physiol Heart Circ Physiol. 2007;292:H2425-H2431 (Pubitemid 47084625)